Shopping Cart
- Remove All
- Your shopping cart is currently empty
SRX3207 is an inhibitor of Syk and PI3K and relieves tumor immunosuppression.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $51 | In Stock | |
5 mg | $130 | In Stock | |
10 mg | $195 | In Stock | |
25 mg | $316 | In Stock | |
50 mg | $416 | In Stock | |
100 mg | $583 | In Stock | |
200 mg | $788 | In Stock |
Description | SRX3207 is an inhibitor of Syk and PI3K and relieves tumor immunosuppression. |
Targets&IC50 | ZAP70:1300 nM (IC50), PI3Kα:861 nM (IC50), PI3Kδ:1280 nM (IC50), Syk:10.7 nM (IC50), PI3Kγ:11100 nM (IC50) |
In vitro | The IC50 values are 10.7 nM and 861 nM for Syk and PI3Kα, respectively. SRX3207 (10 μmol/L) blocks p-AKT[1]. |
In vivo | Oral administration of SRX3207 increases antitumor immune response. SRX3207 blocks immunosuppressive MΦ polarization, blocks tumor growth, and increases survival effectively[1]. |
Molecular Weight | 555.65 |
Formula | C29H29N7O3S |
Cas No. | 2254693-15-5 |
Smiles | Cc1nn(cc1CN1CCC1)-c1ccnc(Nc2ccc(cc2)-c2csc3c2oc(cc3=O)N2CCOCC2)n1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
Solubility Information | DMSO: 4.5 mg/mL (8.1 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.